University Hospital Erlangen
Department of Radiation Therapy (289958)
Specialized in: radiation therapy
The Department of Radiation Therapy at the University Hospital Erlangen is one of the newest Centers for Radiation Therapy in Germany. The in the Department offers a comprehensive treatment for malignant diseases. This includes radiotherapy combined with chemotherapy, as well as supportive therapy (e.g. pain therapy and supportive nutrition). The Department is headed by Prof. Dr. med. Rainer Fietkau.
Different tumors require different therapies offered by the state-of-the-art radiation units of the University Hospital Erlangen. The spectrum also includes interventional radiation therapy and local deep hyperthermia.
The focuses of the Department of Radiation Therapy are:
- Percutaneous radiotherapy
- Interventional radiotherapy (brachytherapy)
- Pain radiation
The Department of Radiation Therapy at the University Hospital Erlangen under the direction of Prof. Dr. med. Rainer Fietkau offers the full range of top-class radiation therapy. There are treated all malignant cancers, as well as specific benign tumors, non-neoplastic inflammatory, hormonal and age-related diseases. According to the Focus magazine rating of 2017, the Department of Radiation Therapy at the University Hospital Erlangen ranks among the top German departments specializing in radiation therapy! Physicians, medical physics, radiobiologists, technical assistants and nursing staff maintain a close cooperation with other departments of the University Hospital Erlangen in accordance with the international concepts.
The range of services of the Department of Radiation Therapy includes the following opportunities:
- Organ preserving treatment of breast in women, partial breast radiation. Definitive or consolidating radiotherapy for lymphomas
- Definitive radiochemotherapy of primary unrespectable pancreatic cancer. Total body irradiation before bone marrow transplant in children and adults cardia, lungs, pancreas
- Neoadjuvant chemotherapy of cancer, esophagus
- Organ / function preserving operative radiation therapy (brachytherapy) upon breast and prostate cancer, head and neck tumors, cervical cancer, cervical body cancer, vaginal and vulvar cancer, penile cancer and choroidal melanoma
- Organ / function preserving radiochemotherapy with deep hyperthermia of superficial and muscle-invasive bladder cancer as an alternative to primary cystectomy
- Postoperative and definitive radiochemotherapy of brain tumors
- Primary radiochemotherapy of the upper part of the swallowing apparatus
- Primary radiochemotherapy of anal cancer
- Primary radiochemotherapy of lung cancer (bronchogenic carcinoma)
- Radiochemotherapy of rectal cancer, before surgery (neoadjuvant) and after surgery (adjuvant)
- Radiation exposure of benign tumors, such as degenerative (age-related) joint diseases, endocrine ophthalmology (e.g. Basedow’s disease), Dupuytren or Ledderhose disease (cicatricial degeneration of the plantar or palmar aponeurosis), as well as radiation therapy before and after joint replacement to avoid calcification
- Erlangen, Germany